raloxifene hydrochloride has been researched along with Hypertension in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichikawa, S; Kanda, T; Kasama, S; Kumakura, H; Kurabayashi, M; Murakami, M; Sumino, H; Takahashi, T; Takayama, Y | 1 |
| Nakamura, T; Sakai, A | 1 |
| Mori, S | 1 |
| Boldo, A; White, WB | 1 |
| Abreu, GR; Bissoli, NS; Gonçalves, WL; Gouvêa, SA; Moraes, AN; Moyses, MR; Pires, JG; Romero, WG | 1 |
| Reincke, M | 1 |
| Aldrighi, JM; da Costa, LS; de Oliveira, MA; Gebara, OC; Neto, CD; Rosano, GM; Rubim, VS; Wajngarten, M | 1 |
| Leitzbach, D; Linz, W; Madajka, M; Malinski, T; Weckler, N; Wiemer, G | 1 |
| Chan, YC; Huang, Y; Lau, CW; Leung, FP; Vanhoutte, PM; Yao, X | 1 |
| Ahlbory, K; Böhm, M; Laufs, U; Linz, W; Nickenig, G; Rösen, R; Stamenkovic, D; Stasch, JP; Wassmann, S | 1 |
2 review(s) available for raloxifene hydrochloride and Hypertension
| Article | Year |
|---|---|
[Effects of SERMs on bone health. Efficacy of SERM for incidence of fractures in osteoporotic patients with lifestyle-related diseases].
Topics: Adiponectin; beta Catenin; Diabetes Mellitus, Type 2; Female; Fractures, Spontaneous; Humans; Hyperlipidemias; Hypertension; Life Style; Meta-Analysis as Topic; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risk; Selective Estrogen Receptor Modulators; Signal Transduction; Spinal Fractures; Wnt Proteins | 2010 |
[Pharmacotherapy of osteoporosis accompanied by lifestyle-related diseases].
Topics: Adrenergic beta-Antagonists; Animals; Cardiovascular Diseases; Diabetes Complications; Diphosphonates; Dyslipidemias; Fractures, Bone; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypoglycemic Agents; Life Style; Osteogenesis; Osteoporosis; Raloxifene Hydrochloride; Thiazolidinediones; Vitamin D | 2011 |
1 trial(s) available for raloxifene hydrochloride and Hypertension
| Article | Year |
|---|---|
Effects of hormone replacement therapy or raloxifene on ambulatory blood pressure and arterial stiffness in treated hypertensive postmenopausal women.
Topics: Administration, Oral; Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Estrogen Replacement Therapy; Female; Humans; Hypertension; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Vascular Resistance | 2004 |
8 other study(ies) available for raloxifene hydrochloride and Hypertension
| Article | Year |
|---|---|
Effects of raloxifene on the renin-angiotensin-aldosterone system and blood pressure in hypertensive and normotensive osteoporotic postmenopausal women.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Case-Control Studies; Female; Humans; Hypertension; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Renin-Angiotensin System; Selective Estrogen Receptor Modulators | 2010 |
Blood pressure effects of the oral contraceptive and postmenopausal hormone therapies.
Topics: Aged; Animals; Blood Pressure; Contraceptives, Oral, Hormonal; Estrogen Replacement Therapy; Female; Humans; Hypertension; Middle Aged; Postmenopause; Raloxifene Hydrochloride; Renin-Angiotensin System; Selective Estrogen Receptor Modulators | 2011 |
Raloxifene reduces blood pressure in hypertensive animals after ovarian hormone deprivation.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Diuresis; Drug Evaluation, Preclinical; Female; Hypertension; Nitrates; Nitrites; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Wistar; Sodium | 2011 |
My doctor wanted me to start taking Evista (raloxifene hydrochloride) for osteoporosis, but I'm worried because the drug is linked to a risk of blood clots. I have mild hypertension that I manage with medications, diet and exercise. Do you think the drug
Topics: Bone Density Conservation Agents; Diet; Exercise; Female; Humans; Hypertension; Osteoporosis; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Stroke; Thrombosis | 2010 |
[Diabetes, Conn syndrome and osteoporosis. What is new in diagnosis and therapy?].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Coronary Disease; Diabetes Mellitus, Type 2; Diphosphonates; Estrogen Antagonists; Female; Fractures, Bone; Humans; Hyperaldosteronism; Hyperglycemia; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators | 2003 |
Restoration of endothelial function via enhanced nitric oxide synthesis after long-term treatment of raloxifene in adult hypertensive rats.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Bradykinin; Endothelium, Vascular; Female; Heart Rate; Hypertension; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Inbred SHR; Selective Estrogen Receptor Modulators; Superoxides | 2005 |
Raloxifene modulates pulmonary vascular reactivity in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Endothelium, Vascular; Hypertension; Lung; Male; Pulmonary Artery; Raloxifene Hydrochloride; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Selective Estrogen Receptor Modulators; Vasoconstriction | 2007 |
Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production.
Topics: Animals; Antihypertensive Agents; Aorta; Blood Pressure; Cells, Cultured; Culture Techniques; Endothelium, Vascular; Hypertension; Male; Muscle, Smooth, Vascular; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidative Stress; Raloxifene Hydrochloride; Rats; Rats, Inbred SHR; Rats, Wistar; Reactive Oxygen Species; Selective Estrogen Receptor Modulators; Vasoconstriction; Vasodilation | 2002 |